Clin2
NCT07551531Likely a fitNot yet recruiting

Blood test to check kidney transplant health

Kidney Transplant

Part of Immune system & allergy, Kidney & urinary clinical trials.

This study tests a blood test called GraftAssure that may help doctors detect if your body is rejecting your new kidney. By monitoring this, the test could help prevent kidney damage and improve transplant outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
5,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be at least 18 years old.
  • You must be at least 2 weeks past your kidney transplant.
  • You must agree to follow all study procedures and provide informed consent.
  • You cannot have received a kidney from an identical twin.
  • You cannot have had another organ transplant (other than a kidney) or a bone marrow/stem cell transplant.
  • You cannot be pregnant or have certain cancers.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07718633Not yet recruiting
Blood test for kidney transplant rejection

This trial tests a blood test that may help monitor kidney transplant health by detecting signs of rejection earlier. It aims to see if using this blood test can lead to better long-term outcomes for transplant recipients.

NCT06801262Recruiting
New Blood Test to Detect Kidney Transplant Rejection

This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.

Bologna
NCT07006831Recruiting
Blood study for kidney transplant patients

This study collects blood and leftover donor samples from kidney transplant recipients who need a biopsy. The goal is to improve monitoring after transplant.

San Diego, California
NCT06025240Recruiting
Better antibody monitoring after kidney transplant

This study tests a new way to monitor harmful antibodies after a kidney transplant. It may help prevent transplant rejection over time.

Liverpool, Merseyside
NCT06351488Recruiting
Detecting kidney DNA to spot organ rejection early

This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.

Paris
NCT07060716Recruiting
Blood test to monitor kidney transplant health

This study is testing a blood test that looks for tiny pieces of the donor's DNA in your blood to check how your new kidney is doing. It may help doctors monitor your transplant and spot problems early, possibly without needing a biopsy.

Los Angeles, California

Hear when a new Kidney Transplant trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.